Peripheral blood B lymphocytes in multiple myeloma

Area of Science:

• Immunology
• Hematology
• Oncology

Background:

• Multiple myeloma (MM) originates from terminally differentiated B lineage cells.
• Alterations in circulating B cells are expected in patients with MM.

Purpose of the Study:

• To investigate peripheral blood B cell populations in untreated MM patients.
• To determine if B cell characteristics correlate with survival in MM.

Main Methods:

• Flow cytometry analysis of peripheral blood B cells.
• Comparison of 45 untreated MM patients against 25 age-matched controls.
• Assessment of CD20+ cell counts and expression of immunoglobulin light chains.

Main Results:

• MM patients showed significantly decreased total lymphocyte counts and CD20+ cell numbers.
• No evidence of clonal B cell excess or light chain isotype suppression was found.
• The percentage of peripheral blood CD20+ cells was a significant prognostic factor for survival in MM.

Conclusions:

• Peripheral blood B cell populations are altered in multiple myeloma.
• The proportion of CD20+ B cells in peripheral blood is a valuable prognostic indicator for MM patient survival.